FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Cardiologist Sends Affidavit to Hahn

Wisconsin cardiologist Nalini Rajamannan contacts FDA commissioner Stephen Hahn over the agencys decision not to provide information to patients who w...

Federal Register

Animal User Fee Reporting Info Collection

Federal Register notice: FDA seeks comments on an information collection extension for Reporting Associated With Animal Drug and Animal Generic Drug U...

Federal Register

Info Collection on Electronic Product Radiation

Federal Register notice: FDA seeks comments on an information collection extension for Electronic Products 21 CFR Parts 1000 Through 1050.

Federal Register

Cardene Not Withdrawn Over Safety/Efficacy: FDA

Federal Register notice: FDA determines that Chiesi USAs Cardene (nicardipine hydrochloride) injection, 25 mg/10 ml, was not withdrawn from sale for s...

Human Drugs

BsUFA User Fee Assessment Guidance

FDA publishes a guidance on changes in the Biosimilar User Fee program.

Medical Devices

FDA Cites GE Healthcare Cybersecurity Issues

FDA highlights potential cybersecurity vulnerabilities in some GE Healthcare Clinical Information Central Stations and Telemetry Servers.

Federal Register

Class 2 for Computer Triage/Notification Software

Federal Register notice: FDA classifies radiological computer-aided triage and notification software into Class 2 (special controls).

Federal Register

CADx Software for Suspect Cancer Lesions Into Class 2

Federal Register notice: FDA classifies the radiological computer-assisted diagnostic (CADx) software for lesions suspicious for cancer into Class 2 (...

Federal Register

Medical Image Analyzers Reclassified as Class 2

Federal Register notice: FDA issues an order to reclassify medical image analyzers, including CADe devices, for mammography breast cancer, ultrasound ...

Human Drugs

Purell Hand Sanitizers Unapproved New Drugs: FDA

FDA warns Gojo Industries that its Purell Advanced Hand Sanitizer products are unapproved new drugs that dont meet requirements for the tentative fina...